T1	intervention 0 18	Expressive writing
T2	No-of-participants 508 511	120
T3	control 556 582	control group (no writing)
T4	eligibility 178 207	early breast cancer survivors
T5	duration 749 767	4 consecutive days
T6	outcome-Measure 775 790	quality-of-life
T7	No-of-participants 1046 1048	97
T8	outcome 1311 1347	improved the quality-of-life outcome
